Back to dashboard
CommercialCoverageMedium impact

Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer

Blue Cross & Blue Shield of Mississippi·MS · Oncology, General Surgery, Pathology·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

BCBS Mississippi has issued a new medical policy (A.2.04.36) defining coverage criteria for genetic expression assays in breast cancer tumor tissue. This policy establishes when genetic testing to determine prognosis and guide treatment decisions in breast cancer patients will be covered.

Action Required

Action needed
Immediately: Review the new BCBS Mississippi medical policy A.2.04.36 for genetic expression assays in breast cancer. Billing team should obtain the complete policy document to understand specific coverage criteria, prior authorization requirements, and documentation needs for breast cancer genetic testing claims. Update billing procedures to ensure compliance with new coverage guidelines before submitting related claims.

Related policy hubs